• End date
    Jul 15, 2025
  • participants needed
  • sponsor
    Medtronic Vascular
Updated on 15 October 2020
K Wandrey
Primary Contact
Universit tsklinikum Erlangen (8.7 mi away) Contact
+75 other location
systolic blood pressure
antihypertensive drugs
ambulatory blood pressure monitoring
24-hour ambulatory blood pressure monitoring


The purpose of this study is to test the hypothesis that renal denervation decreases blood pressure and is safe when studied in the presence of up to three standard antihypertensive medications.

Treatment Symplicity Spyral™ multi-electrode renal denervation system, Sham Procedure
Clinical Study IdentifierNCT02439775
SponsorMedtronic Vascular
Last Modified on15 October 2020

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.


Yes No Not Sure

Inclusion Criteria

Is your age between 20 yrs and 80 yrs?
Gender: Male or Female
Do you have any of these conditions: Diabetes and Hypertension or Hypertension or Vascular Diseases or High Blood Pressure (Hypertension) or Cardiovascular Disease or High Blood Pressure ...?
Individual has office systolic blood pressure (SBP) 150 mmHg and <180 mmHg and a diastolic blood pressure (DBP) 90 mmHg when receiving a medication regimen of one, two, or three antihypertensive medication classes
Individual has 24-hour Ambulatory Blood Pressure Monitoring (ABPM) average SBP 140 mmHg and < 170 mmHg

Exclusion Criteria

Individual lacks appropriate renal artery anatomy
Individual has estimated glomerular filtration rate (eGFR) of <45\
Individual has type 1 diabetes mellitus or poorly-controlled type 2 diabetes mellitus
Individual has one or more episodes of orthostatic hypotension
Individual requires chronic oxygen support or mechanical ventilation other than nocturnal respiratory support for sleep apnea
Individual has primary pulmonary hypertension
Individual is pregnant, nursing or planning to become pregnant
Individual has frequent intermittent or chronic pain that results in treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) for two or more days per week over the month prior to enrollment
Individual has stable or unstable angina within 3 months of enrollment, myocardial infarction within 3 months of enrollment; heart failure, cerebrovascular accident or transient ischemic attack, or atrial fibrillation at any time
Individual works night shifts
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer


user name

Annotated by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No made yet